http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004167111-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate | 2003-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58019271dac33449e75a37157b248f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7164dfcc253849aadc7af6e18af0857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3185b16c1601515ddd06c712703e2531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_712394a7f129d6e851b50e69b5cf71c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a71d6675eaeaa8fafce78cfd08c645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9f5ef22e679d375b17c34d9b836c8e |
publicationDate | 2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2004167111-A1 |
titleOfInvention | Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy |
abstract | The pharmaceutical preparations for treating side effects, such as hot flashes, prostate enlargement and gynecomastia, during and/or after treatment with analogs or antagonists of gonadotropin-releasing hormone (GnRHa therapy) contain an effective amount of a chemically modified derivative of 17α-estradiol, a chemically modified derivative of 17β-estradiol and/or a chemical modified derivative of estriol. Pharmaceutical preparations containing estra 1,3,5(10)-triene-3,17β-diol-17-valerate as the effective ingredient are particularly preferred. |
priorityDate | 1998-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.